Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis.
Author: Haycock PC1, Heydon EE2, Kaptoge S2, Butterworth AS2, Thompson A3, Willeit P4.
Affiliation:
1Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK Medical Research Council Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, UK philip.haycock@bristol.ac.uk. 2Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK. 3Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK Roche, Welwyn Garden City, UK. 4Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK Department of Neurology, Innsbruck Medical University, Austria.
Conference/Journal: BMJ
Date published: 2014 Jul 8
Other:
Volume ID: 349 , Pages: g4227 , Special Notes: doi: 10.1136/bmj.g4227 , Word Count: 319
OBJECTIVE:
To assess the association between leucocyte telomere length and risk of cardiovascular disease.
DESIGN:
Systematic review and meta-analysis.
DATA SOURCES:
Studies published up to March 2014 identified through searches of Medline, Web of Science, and Embase.
ELIGIBILITY CRITERIA:
Prospective and retrospective studies that reported on associations between leucocyte telomere length and coronary heart disease (defined as non-fatal myocardial infarction, coronary heart disease death, or coronary revascularisation) or cerebrovascular disease (defined as non-fatal stroke or death from cerebrovascular disease) and were broadly representative of general populations-that is, they did not select cohort or control participants on the basis of pre-existing cardiovascular disease or diabetes.
RESULTS:
Twenty four studies involving 43 725 participants and 8400 patients with cardiovascular disease (5566 with coronary heart disease and 2834 with cerebrovascular disease) were found to be eligible. In a comparison of the shortest versus longest third of leucocyte telomere length, the pooled relative risk for coronary heart disease was 1.54 (95% confidence interval 1.30 to 1.83) in all studies, 1.40 (1.15 to 1.70) in prospective studies, and 1.80 (1.32 to 2.44) in retrospective studies. Heterogeneity between studies was moderate (I(2)=64%, 41% to 77%, Phet<0.001) and was not significantly explained by mean age of participants (P=0.23), the proportion of male participants (P=0.45), or distinction between retrospective versus prospective studies (P=0.32). Findings for coronary heart disease were similar in meta-analyses restricted to studies that adjusted for conventional vascular risk factors (relative risk 1.42, 95% confidence interval 1.17 to 1.73); studies with ≥200 cases (1.44, 1.20 to 1.74); studies with a high quality score (1.53, 1.22 to 1.92); and in analyses that corrected for publication bias (1.34, 1.12 to 1.60). The pooled relative risk for cerebrovascular disease was 1.42 (1.11 to 1.81), with no significant heterogeneity between studies (I(2)=41%, 0% to 72%, Phet=0.08). Shorter telomeres were not significantly associated with cerebrovascular disease risk in prospective studies (1.14, 0.85 to 1.54) or in studies with a high quality score (1.21, 0.83 to 1.76).
CONCLUSION:
Available observational data show an inverse association between leucocyte telomere length and risk of coronary heart disease independent of conventional vascular risk factors. The association with cerebrovascular disease is less certain.
© Haycock et al 2014.
PMID: 25006006
BACK
